Reports

Featured reports

Alcohol, tobacco & other drugs in Australia 

The consumption of alcohol, tobacco and other drugs is a major cause of preventable disease and illness in Australia. This report consolidates the most recently available information on alcohol, tobacco and other drug use in Australia, including key trends in the availability, consumption, harms and treatment for vulnerable populations. Further, information on a range of health, social and economic impacts of alcohol, tobacco and other drug use are highlighted.

National Drug Strategy Household Survey 2016: detailed findings 

This 2016 National Drug Strategy Household Survey report shows that: the decline in daily smoking slowed in 2016 but improvements were seen among people living in the lowest socioeconomic area; certain groups disproportionately experience drug-related risks and recent use of illicit drugs was particularly high for people who identified as homosexual or bisexual; just under 4 in 10 Australians either smoked daily, drank alcohol in ways that put them at risk of harm or used an illicit drug in the previous 12 months.

Latest reports

Opioid harm in Australia: and comparisons between Australia and Canada 

Opioid use and its associated harms is an issue of great public health interest, both within Australia and internationally. This report shows that opioid harms are an issue in both Australia and Canada. Rates of opioid deaths and opioid poisoning hospitalisations in Australia increased in the last 10 years. In 2016, pharmaceutical opioids were involved in more opioid deaths and opioid poisoning hospitalisations than heroin. 

National opioid pharmacotherapy statistics (NOPSAD) 2017 

On a snapshot day in 2017, almost 50,000 clients received pharmacotherapy treatment for their opioid dependence at 2,732 dosing points around Australia.

As in previous years, methadone was the most common pharmacotherapy drug, with around two-thirds (60%) of clients treated with this drug.

There were 3,074 prescribers of opioid pharmacotherapy drugs, an increase of 3% from 2016.

Impact of alcohol and illicit drug use on the burden of disease and injury in Australia: Australian Burden of Disease Study 2011  

This report quantifies the health impact that alcohol and illicit drug use place on Australia, including as risk factors for other diseases and injuries. It estimates that alcohol and illicit drugs were collectively responsible for 6.7% of Australia’s disease burden in 2011. The report highlights that health inequalities exist, with lower socioeconomic groups and more remote areas generally experiencing higher rates of disease burden due to alcohol and illicit drug use.

Family, domestic and sexual violence in Australia, 2018 

Family, domestic and sexual violence is a major health and welfare issue. It occurs across all ages, socioeconomic and demographic groups but mainly affects women and children. Indigenous women, young women and pregnant women are particularly at risk. This report explores the extent, impact and cost of family, domestic and sexual violence in Australia, and looks at what could be done to fill important data gaps.  

Non-medical use of pharmaceuticals: trends, harms and treatment 2006–07 to 2015–16 

The non-medical use of pharmaceuticals is common—about 1 million Australians (4.8%) aged 14 years or older reported recent non-medical use of a pharmaceutical drug. Prescriptions for opioid analgesics continued to increase and chronic pain and mental illness was higher among people with recent non-medical use of a pharmaceutical. Drug-induced deaths where benzodiazepines or other opioids like oxycodone and codeine were present, has more than doubled over the past decade.

National opioid pharmacotherapy statistics (NOPSAD) 2016 

On a snapshot day in 2016, almost 34,000 clients across 6 jurisdictions received pharmacotherapy treatment for their opioid dependence at 2,011 dosing points. There were 1,472 authorised prescribers of opioid pharmacotherapy drugs.

Data for Victoria and the Australian Capital Territory were unavailable at the time of the initial release on 29 March 2017. Additional supplementary tables were added on 14 November 2017 to include data for these jurisdictions as well as updated Australian totals.

National Drug Strategy Household Survey (NDSHS) 2016—key findings  

This web-based release presents a summary of the national findings from the 2016 National Drug Strategy Household Survey. The 2016 NDSHS show that younger people (aged under 30) were smoking less, drinking less and using fewer illicit drugs in 2016 than in 2001. However, for people in their 40s, 50s and 60s, there was little to no change in drug usage behaviours over this period but their use of some drugs has increased between 2013 and 2016.

National opioid pharmacotherapy statistics (NOPSAD) 2015 

On a snapshot day in 2015, over 48,000 clients received pharmacotherapy treatment for their opioid dependence at 2,589 dosing points around Australia.

As in previous year, methadone was the most common pharmacotherapy drug, with around two-thirds (66%) of clients treated with this drug. There were 2,556 prescribers of opioid pharmacotherapy drugs, an increase of 9% from 2014.

National opioid pharmacotherapy statistics 2014 

On a snapshot day in 2014, over 48,000 clients received pharmacotherapy treatment for their opioid dependence at 2,432 dosing points around Australia. As in previous year, methadone was the most common pharmacotherapy drug, with around two-thirds (67%) of clients treated with this drug. There were 2,319 prescribers of opioid pharmacotherapy drugs, an increase of 15% from 2013.

National Drug Strategy Household Survey detailed report: 2013 

This 2013 National Drug Strategy Household Survey report shows that: - fewer Australians are smoking daily and are smoking less cigarettes; - fewer people are exceeding the lifetime risk and single occasion risk guidelines for alcohol use; - overall illicit drug use has remained stable but some drugs have declined and some have increased; - alcohol continues to be the drug of most concern to the community but an increasing number of people are concerned about meth/amphetamines.

National opioid pharmacotherapy statistics 2013 

On a snapshot day in 2013, over 47,000 clients received pharmacotherapy treatment for their opioid dependence at 2,355 dosing points around Australia. As in previous years, methadone was the most common pharmacotherapy drug, with around two-thirds (68%) of clients treated with this drug. There were 2,025 prescribers of opioid pharmacotherapy drugs, an increase of 15% from 2012.

The mental health of prison entrants in Australia: 2010 

This bulletin reports on the mental health of prison entrants, based on data from the 2010 National Prisoner Health Census. In 2010: - Nearly one third of prison entrants reported that they had mental health issues (a rate 2.5 times higher than the general population) - 16% of prison entrants took medication for mental health issues - 3 in 4 prison entrants who were taking mental health medication also used illicit drugs during the previous 12 months

Drugs in Australia 2010: tobacco, alcohol and other drugs 

Drugs in Australia 2010 provides a comprehensive summary of Australians' consumption of alcohol, tobacco and other drugs and use of treatment services, drawing on the latest statistics from major national collections. It also includes information about drug-related health issues, and drugs in the context of crime and law enforcement.

Measuring alcohol risk in the 2010 National Drug Strategy Household Survey: implementation of the 2009 Alcohol Guidelines 

This report outlines the steps involved to develop a consistent measure for analysing the 2010 National Drug Strategy Household Survey alcohol data. The report details the methods and questions used for reporting single occasion risk and lifetime risk in line with the National Health and Medical Research Council's Australian Guidelines to Reduce Health Risks from Drinking Alcohol. The development of these new guidelines impacted interpretation of the proportion of the population drinking alcohol at risky levels.

2010 National Drug Strategy Household Survey report 

This 2010 National Drug Strategy Household Survey report shows: positive and significant reductions since 2007 in daily tobacco smoking; mixed findings on alcohol consumption and risk; and a small overall rise in illicit drug use. In terms of attitudes to drugs, excessive alcohol use and tobacco smoking were nominated as the two most serious concerns to the community - and there were higher levels of support than previously for tobacco and alcohol harm reduction policies.

Reducing alcohol and other drug-related harm 

Rates of risky consumption of alcohol and other drugs among Indigenous Australians are generally twice those in the non-Indigenous population, and are both a consequence of - and contribute to - the gap in health and social well-being. This resource sheet discusses patterns of harmful use of alcohol and other drugs within Indigenous communities and evaluates the effectiveness of various intervention strategies. It outlines what works, what doesn't, and what further research is needed, regarding strategies concerning supply reduction, demand reduction, and harm reduction.

2007 National Drug Strategy Household Survey: detailed findings 

This report extends the analysis presented in the 2007 National Drug Strategy Household Survey: first results by providing more detailed information on drug use prevalence, drug-related behaviours and incidents, and support for drug-related policy and legislation. This report, along with others in the Drug Statistics Series, will be a useful resource for policy-makers, planners and researchers interested in drug-related matters.

2007 National Drug Strategy Household Survey: state and territory supplement 

This report presents data on patterns of drug use in each of the states and territories. It supplements the national findings from the '2007 National Drug Strategy Household Survey: first results' report, published in April 2008. The results are based on a survey of more than 23,000 Australians conducted in 2007, and provide profiles of drug use and community attitudes in each of the states and territories.

2007 National Drug Strategy Household Survey: first results 

2007 National Drug Strategy Household Survey: first results presents summary data collected in Australia's most comprehensive national survey of drug use and related issues. Comparisons with previous surveys are presented, along with population estimates of the numbers of consumers of tobacco, alcohol and illicit drugs. Key results on drug-related awareness, knowledge and behaviour are features of this report. This report is the 20th in the Australian Institute of Health and Welfare's Drug Statistics Series. Future reports in the series will cover extended analysis of the 2007 results and a comprehensive summary of major drug use statistical collections. This report and others in the series are useful resources for policy-makers, researchers and professionals interested in drug-related issues.